动RNA结合蛋白:在瘤进展中的多功能调节剂
Wangyu Zhu1,2, Weiwei Yang1,2, Guoping Sun3
1Cell and Molecular Biology Laboratory, Zhoushan Hospital of Wenzhou Medical University, Zhoushan, Zhejiang, China.
Annals of medicine
|December 23, 2024
概括
震 (QKI) 调节RNA处理并影响瘤进展,同时作为瘤基因和瘤抑制剂. 需要进一步的研究才能充分理解它在癌症发展和治疗中的复杂作用.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 在RNA生物学,RNA生物学.
背景情况:
- 动 (QKI),一个STAR家族成员,对于RNA处理至关重要,包括拼接,运输和翻译.
- 异常的QKI表达或突变通过改变RNA和蛋白质表达来促进瘤的进展.
- 在癌症中QKI的作用是复杂的,根据瘤类型,它既作为瘤基因又作为瘤抑制剂起作用.
研究的目的:
- 审查QKI异型和瘤进展中的功能.
- 分析QKI调节的基因表达对癌症的影响.
- 探索QKI作为瘤学中的预测标记物和治疗点的潜力.
主要方法:
- 系统审查最近的科学文献.
- 总结QKI在瘤进展中的功能性改变.
主要成果:
- QKI调节了转录后的基因表达,影响了替代拼接,聚氨基化,mRNA稳定性和局部化.
- QKI失调与瘤扩散,转移,血管新生,干细胞,微环境和治疗敏感性相关.
- QKI的改变可以作为瘤诊断和预后的潜在生物标志物.
结论:
- 在瘤进展中,QKI充当关键瘤抑制剂或瘤基因,受拼接变异和瘤微环境的影响.
- 了解QKI的不同作用需要对其在癌症调节中的机制和功能进行持续的研究.
相关概念视频
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Regulation of Expression at Multiple Steps
869
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
869
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Negative Regulator Molecules
35.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K
Regulation of Nuclear Protein Sorting
2.4K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.4K


